SummaryGlobal Market Direct’s pharmaceuticals report, “Peregrine Pharmaceuticals,Inc. - Product Pipeline Review - 2012” provides data on the PeregrinePharmaceuticals, Inc.’s research and development focus. The report includesinformation on current developmental pipeline, complete with latestupdates, and features on discontinued and dormant projects.This report is built using data and information sourced from Global MarketsDirect’s proprietary databases, Peregrine Pharmaceuticals, Inc.’s corporatewebsite, SEC filings, investor presentations and featured press releases,both from Peregrine Pharmaceuticals, Inc. and industry-specific third partysources, put together by Global Markets Direct’s team.
Scope- Peregrine Pharmaceuticals, Inc. - Brief Peregrine Pharmaceuticals, Inc. overviewincluding business description, key information and facts, and its locations andsubsidiaries.- Review of current pipeline of Peregrine Pharmaceuticals, Inc. human therapeuticdivision.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.Reasons to buy- Evaluate Peregrine Pharmaceuticals, Inc.’s strategic position with total access todetailed information on its product pipeline.- Assess the growth potential of Peregrine Pharmaceuticals, Inc. in its therapy areasof focus.- Identify new drug targets and therapeutic classes in the Peregrine Pharmaceuticals,Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in thoseareas.- Exploit in-licensing opportunities by identifying windows of opportunity to fillportfolio gaps.
Table of Contents :List of Tables 5List of Figures 6Peregrine Pharmaceuticals, Inc. Snapshot 7Peregrine Pharmaceuticals, Inc. Overview 7Key Information 7Key Facts 7Peregrine Pharmaceuticals, Inc. – Research and Development Overview 8Key Therapeutic Areas 8Peregrine Pharmaceuticals, Inc. – Pipeline Review 11Pipeline Products by Stage of Development 11Pipeline Products – Monotherapy 12Pipeline Products – Combination Treatment Modalities 13Peregrine Pharmaceuticals, Inc. – Pipeline Products Glance 14Peregrine Pharmaceuticals, Inc. Clinical Stage Pipeline Products 14Phase II Products/Combination Treatment Modalities 14Phase I Products/Combination Treatment Modalities 15Peregrine Pharmaceuticals, Inc. – Early Stage Pipeline Products 16Pre-Clinical Products/Combination Treatment Modalities 16Peregrine Pharmaceuticals, Inc. – Drug Profiles 17……………….
Please follow link if you want More RelatedReports :Product Pipeline Review – 2012http://www.aarkstore.com/search/viewresults.asp?search=ProductPipeline Review – 2012&PubId=&pagenum=1
For More details about above & otherReports plz contact :LavanyaAarkstore.comContact: Marketing team Mob.No.918149852585Email: email@example.com ,firstname.lastname@example.orgURL: http://www.aarkstore.comhttp://in.linkedin.com/in/aarkstorehttp://www.facebook.com/aarkstore